Clinical Trials Browser

Phase 1/2 × Inoperable Locally Advanced HER2-Negative Breast Cancer × pembrolizumab × Clear all

NCT06942234 2025-09-17

Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1/2 Recruiting

Inoperable Locally Advanced HER2-Negative Breast Cancer